Basiliximab

Names

[ Name ]:
Basiliximab

Biological Activity

[Description]:

Basiliximab (CHI 621) is a recombinant chimeric murine/human IgG1 monoclonal anti-interleukin-2 receptor antibody. Basiliximab can be used for the research of renal transplantation[1].

[Related Catalog]:

Signaling Pathways >> Immunology/Inflammation >> Interleukin Related

Research Areas >> Inflammation/Immunology

[Target]

Interleukin-2 receptor[1]

[In Vitro]

Basiliximab specifically inhibits T lymphocyte proliferation by binding to the IL-2Rα[1]. Basiliximab binds only to activated lymphocytes and macrophages/monocytes[3]. Basiliximab does not affect resting T lymphocytes that do not express IL-2Rα[3].

[In Vivo]

Basiliximab (CHI 621) (0.07 mg/rat; i.v.; once) decreases total placental natural killer cells in reduced uterine perfusion pressure (RUPP) rats[2]. Animal Model: Timed-pregnant Sprague Dawley (SD) rats, reduced uterine perfusion pressure (RUPP) rat model of placental ischemia[2] Dosage: 0.07 mg/rat Administration: IV infusion, once Result: Decreased total placental natural killer cells. Had no effect to lower MAP or improve pup weight and placental weight.

[References]

[1]. McKeage K, et al. Basiliximab: a review of its use as induction therapy in renal transplantation. BioDrugs. 2010 Feb 1;24(1):55-76.

[2]. Cunningham M W, et al. The Role of Interleukin‐2 (IL‐2) in Natural Killer Cell (NK) Activation and Hypertension in a Preclinical Rat Model of Preeclampsia. The FASEB Journal, 2018, 32: 911.1-911.1.

[3]. Chapman TM, et al. Basiliximab: a review of its use as induction therapy in renal transplantation. Drugs. 2003;63(24):2803-35.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Basiliximab

Names

Biological Activity

Chemical & Physical Properties

Related Compounds